As of September 2024, Can-Fite BioPharma has a market cap of $13.63M. This makes Can-Fite BioPharma the world's 31670th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $12.65M | 0.00% |
2023 | $12.65M | -69.05% |
2022 | $40.88M | -42.86% |
2021 | $71.54M | -26.13% |
2020 | $96.85M | -46.79% |
2019 | $182.02M | -83.89% |
2018 | $1.13B | -7.46% |
2017 | $1.22B | -45.04% |
2016 | $2.22B | -20.64% |
2015 | $2.80B | -16.76% |
2014 | $3.36B | -30.85% |
2013 | $4.86B | 20.00% |
2012 | $4.05B | -25.67% |
2011 | $5.45B | -39.62% |
2010 | $9.03B | 17.78% |
2009 | $7.67B | 145.14% |
2008 | $3.13B | -63.29% |
2007 | $8.52B | -38.70% |
2006 | $13.89B | -15.78% |
2005 | $16.50B | - |